Ken Griffin Oncology Institute, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 91,337 shares of TOI stock, worth $19,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,337
Previous 269,704
66.13%
Holding current value
$19,180
Previous $124,000
75.81%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TOI
# of Institutions
35Shares Held
17.5MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY3.36MShares$705,6100.02% of portfolio
-
Tiff Advisory Services Inc2.63MShares$552,9050.29% of portfolio
-
Cincinnati Insurance CO2.03MShares$427,1490.01% of portfolio
-
Kent Lake Pr LLC Anasco, PR2MShares$420,0000.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$374,5250.0% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $15.4M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...